SM-13496

· Sumitomo Pharma Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for SM-13496, covering 2018-10-19 to 2019-07-25. Get the full timeline:

Most recent: Clinical Trial Update: A Phase III Study of SM-13496 in Patients With Bipolar I Depression. [Phase 3]